BioSpace News Archive

LDC Receives the City of Dortmund Business Award

The Lead Discovery Center has won Dortmund’s Business Prize, awarded yearly by the Wirtschaftsförderung and the Sparkasse Dortmund.

March 31, 2019
·
2 min read
Drug Development

Auris Medical Announces Randomization of First Dose Cohort in AM-201 Phase 1b Proof-of-Concept Study

Auris Medical Holding Ltd. announced that the first cohort of subjects have been randomized in its Phase 1b proof-of-concept trial of AM-201, the Company’s investigational drug for the prevention of antipsychotic-induced weight gain and somnolence.

March 31, 2019
·
6 min read
Deals

Pharming Group announces publication of its Annual Report 2018 and a provisional commitment to invest in supplier

Annual Report 2018 is available for download on the Pharming website

March 31, 2019
·
5 min read
Job Trends

ClinOne, Inc. Named Top 10 eClinical Company by Pharma Tech Outlook Magazine

ClinOne, a mobile clinical trial management solution, named Top 10 eClinical Company for 2019.

March 31, 2019
·
1 min read
Drug Development

ASIT biotech’s Scientific Advisory Boards (SAB) provide positive recommendations on the clinical development of gp-ASIT+™

The SAB, composed of international experts in the field of allergy immunotherapy, acknowledged the clinical benefits of gp-ASIT+™ and confirmed the interest of a follow-up study to enhance the future market positioning and differentiation of the compound.

March 31, 2019
·
3 min read
Drug Development

Eisai: Data Safety Monitoring Board Recommends Continuation of Phase III Clinical Studies of Bace Inhibitor Elenbecestat in Early Alzheimer’s Disease

Eisai Co., Ltd. announced that in the 8th meeting of the Data Safety Monitoring Board for the global Phase III clinical studies on the investigational oral BACE inhibitor elenbecestat in early Alzheimer’s disease, the DSMB reviewed safety data including the potential for decline in cognition, and recommended the continuation of the studies.

March 31, 2019
·
3 min read
Uni-Bio Science Group (0690.HK) - 2018 Annual Results Enhanced Market Penetration of Core Marketed Products Pipeline Products Witnessed a Steady Progress to Launch Commencement of CMO Service to Fully Harness Asset Values

A fully integrated biopharmaceutical company - Uni-Bio Science Group Limited, is pleased to announce its annual results for the year ended 31 December 2018, as well as its comparatively figures for the year ended 31 December 2017.

March 31, 2019
·
8 min read
Deals

Galapagos NV (Euronext & NASDAQ: GLPG) published its annual report for the financial year 2018

Galapagos NV published its annual report for the financial year 2018.

March 31, 2019
·
3 min read
Drug Development

Apexigen Announces New Clinical Data On APX005M In Combination Therapy For Pancreatic Cancer At The AACR Annual Meeting 2019

APX005M in Combination Therapy was Well Tolerated and Induced Tumor Shrinkage in 20 of 24 Patients with Metastatic Pancreatic Cancer, Several Patients on Therapy for Over a Year

March 31, 2019
·
5 min read
Biotech Beach

LAM Announces New Data Demonstrating High Diagnostic Potential Of Cell-Free DNA Methylation Assay For Early, Non-Invasive Detection Of Liver, Breast And Colorectal Cancers At AACR 2019

Study Data Demonstrate High Sensitivity And Specificity Of IvyGene Test In The Diagnosis Of Liver, Breast And Colorectal Cancers

March 31, 2019
·
2 min read